The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2024

Filed:

Mar. 01, 2019
Applicant:

Inflazome Limited, Dublin, IE;

Inventors:

Matthew Cooper, Cambridge, GB;

David Miller, Cambridge, GB;

Angus Macleod, Cambridge, GB;

Jonathan Shannon, Nottingham, GB;

Assignee:

INFLAZOME LIMITED, Dublin, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/18 (2006.01); C07D 401/12 (2006.01); C07D 213/04 (2006.01); C07D 333/04 (2006.01); C07D 307/34 (2006.01);
U.S. Cl.
CPC ...
C07D 231/18 (2013.01);
Abstract

The present invention relates to sulfonylureas and sulfonylthioureas of formula (I) comprising a 5-membered heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is di-substituted at the 3- and 4-positions relative to the point of attachment of the sulfonyl group, and wherein the group attached to the terminal nitrogen atom of the urea group is either a 1,2,3,5,6,7-hexahydro-s-indacen-4-yl group substituted at the 8-position, or a heteroaryl group substituted at the alpha and alpha′ positions. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.


Find Patent Forward Citations

Loading…